Regeneron: I’m Not Concerned About The Declining ROIC And Operating Margins (NASDAQ:REGN)
· seekingalpha.com
Regeneron Pharmaceuticals, Inc. buy case: Dupixent & Libtayo fuel growth despite volatility & Eylea biosimilar risks; margins to recover. Click for an REGN update.
Regeneron Pharmaceuticals, Inc. ( REGN ), based in Tarrytown, NJ, is a leading biotechnology company with a fantastic track-record of rewarding shareholders ove...